Navigation Links
AcelRx Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
Date:7/10/2012

NEW YORK, July 10, 2012  /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, Chief Executive Officer, Pamela Palmer, Founder and Chief Medical Officer, and Jim Welch, Chief Financial Officer, will co-present at RetailInvestorConferences.com.

DATE:

July 12, 2012

TIME:

12:00 PM EDT

LINK:

www.retailinvestorconferences.com > red "register / watch event now" button

This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.

It is recommended that investors pre-register to save time and receive event updates.

About AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. AcelRx's lead product candidate, the ARX-01 Sufentanil NanoTab PCA System, which is currently in Phase 3 clinical development, is designed to solve the problems associated with post-operative intravenous patient-controlled analgesia which has been shown to cause harm to patients following surgery because of the side effects of morphine, the invasive intravenous route of delivery and the inherent potential for programming and delivery errors associated with the
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AcelRx Pharmaceuticals Announces Pricing of a $10.0 Million PIPE Financing
2. AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results
3. Acella Pharmaceuticals, LLC, files Abbreviated New Drug Application (ANDA) With the U.S. Food & Drug Administration for Topical Corticosteroids Lotion
4. Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
5. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
6. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
7. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
8. Hybrid Fuels, Inc. Announces Name Change to Nouveau Life Pharmaceuticals, Inc.
9. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
10. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
11. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013  Sanofi (EURONEXT: SAN and NYSE: SNY ... JAKARTA , examining the selective JAK2 inhibitor SAR302503 ... dose groups. The primary endpoint assessed the proportion of ... data reported in previous trials, the most common adverse ... will be presented at an upcoming medical congress. ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... Research (A*STAR) and Switzerland,s Cytos Biotechnology ... dosed in a Phase 1 clinical trial with their H1N1 ... particle (VLP) technology. In this first Phase 1 clinical trial, ... its potential to protect against H1N1 influenza infection will be ...
(Date:5/16/2013)... -- Today, the National Patient Advocate Foundation acknowledges that the ... recently approved a bill that would prohibit insurers who ... fees for newer, more expensive oral anti-cancer drugs than ... side-effects. However, the bill was amended to include a ... be a barrier to patients with cancer and in ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... Sparta Systems, Inc., the maker of TrackWise® software ... compliance solutions, today announced that Ascent Healthcare Solutions, ... has selected its TrackWise Enterprise Quality Management System ... compliance with industry regulations. Ascent will deploy ...
... Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) announced ... with the U.S. Food and Drug Administration (FDA) regarding ... series of measures that, when satisfied, will permit Caraco ... manufactured in its Detroit area facilities. The Company is ...
Cached Medicine Technology:Leading Medical Device Provider Chooses TrackWise(R) Software to Optimize Customer Complaint Handling 2Leading Medical Device Provider Chooses TrackWise(R) Software to Optimize Customer Complaint Handling 3Caraco Pharmaceutical Laboratories, Ltd. Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing Operations 2
(Date:5/19/2013)... CA (PRWEB) May 19, 2013 Passages ... addiction treatment center, has announced this week the launch ... through the brands’ social media channels. “We are ... addiction treatment community and to get feedback regarding sobriety, ... Prentiss, CEO and co-founder of the Passages Addiction ...
(Date:5/19/2013)... Minor fender benders and serious car accidents are common ... accident to respond appropriately to the situation. According ... from 2010, accidents, including car accidents, are the fifth ... 2005, automobile accident-related deaths cost over $70 ... drivers and passengers receive treatment in an emergency room ...
(Date:5/18/2013)... Daily Gossip issued a press release last ... their page. John Colston, Daily Gossip’s spokesperson, told the press ... 14-Day Rapid Fat Loss Plan . , Shaun ... healthy at a time when nutritionists and fat loss gurus ... , The diet is based on the Macro-Patterning ...
(Date:5/18/2013)... California (PRWEB) May 18, 2013 Online watch ... be Rolex watch owners at a fraction of ... of luxury timepieces in the world, buyers are urged to ... compared to buying a Rolex watch from a brick-and-mortar store, ... owned Rolex watches priced at unbelievable rates. Although some ...
(Date:5/18/2013)... an original art book for iPad with tango as its ... share their creations based on the traditional music genre through ... . , This work gathers more than 150 original ... idiosyncrasy and passion of tango. Such book is available ... includes a free trailer of the book for readers to ...
Breaking Medicine News(10 mins):Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash 2Health News:Time and Gems Offers Buyers the Largest Collection of Rolex Watches Yet 2Health News:Time and Gems Offers Buyers the Largest Collection of Rolex Watches Yet 3Health News:New Art Book for iPad: Tango Art 2
... TAMPA, Fla., July 23 Bay Area Registered ... drugs and armed himself with a movie to help save ... illness, Burton found an alarming connection between America,s food ingredients ... he,s going to tell the world what he found. The ...
... over recent years. This is fact, but what is not ... centres have shown that family conflict is not a significant ... are striking: in Spain, 24% of women take antidepressants and ... psychopharmaceuticals is often related to family or work-related problems. We ...
... , BATESVILLE, Ind., July 23 Hill-Rom ... release will be issued Thursday, August 6, 2009. You are invited ... at 8 a.m. EDT. , Earnings Release: ... June 30, 2009 will be released to the public after the NYSE ...
... , , NEW YORK, July 23 ... UNICEF,s Next Generation to engage young adults with UNICEF,s mission to ... UNICEF,s Next Generation steering committee is dedicated to reducing the number ... Jenna Bush Hager, a longtime supporter of UNICEF, will lead the ...
... ANAHEIM, Calif., July 23 At the 2009 American ... 26-30 in Anaheim, California, Elekta will demonstrate how the company,s comprehensive ... deliver superior cancer care with precision and ease. , ... plan and deliver radiation treatments, Elekta booth 423 will highlight ...
... , WARREN, N.J., July 23 ... company specializing in dissolving thin film pharmaceutical products, today announced the ... Mr. Clemente will report to Keith J. Kendall, Executive Vice ... Kendall stated, "We are pleased to welcome Ted to MonoSol Rx ...
Cached Medicine News:Health News:Nurse Turned Filmmaker Makes Lifesaving Film 2Health News:Almost 1 quarter of Spanish women take antidepressants 2Health News:Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Third Quarter Earnings Webcast 2Health News:U.S. Fund for UNICEF and Jenna Bush Hager Announce Next Generation Initiative to Improve Lives of Children Around the World 2Health News:Comprehensive VMAT Solution From Elekta on Center Stage at 2009 AAPM Annual Meeting 2Health News:Comprehensive VMAT Solution From Elekta on Center Stage at 2009 AAPM Annual Meeting 3Health News:MonoSol Rx Appoints Theodore Clemente Vice President Business Development 2Health News:MonoSol Rx Appoints Theodore Clemente Vice President Business Development 3
Straight shaft; a 5mm platform with 0.3mm 1x2 teeth; In Titanium....
Fine .12mm Tip With 5mm Platform; In Titanium....
Curved 30mm shaft (in stainless steel); rubber coated for safer use; includes 1.5 meter cable and connectors....
Straight shafts with extra fine pointed tips and 6mm tying platform. Smooth handle with dull finish/...
Medicine Products: